MEDCu Technologies is a biotech company focused on developing a highly effective antimicrobial material and products that incorporates copper microparticles. The patented material is designed to provide a barrier against viral and bacterial contamination.
Leveraging copper’s potent antibacterial properties, MedCu core proposition provides a unique proposition to address acute, critical and chronic wounds. Thecopper-based wound dressings follow the successful commercialization of copper compounds impregnation into various fabrics and polymers after 15 years of research and are protected by 30 patents worldwide.
MedCu is proud to be the first company to gain FDA and CE clearances for marketing copper-based wound dressings.